Glaukos Corporation — Cash Flow (NYSE:GKOS) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 23 M24.7 M33.1 M57.8 M61.3 M14.79 M 14.79 M Cash from investing activities 205.06 M58.23 M44.78 M14.1 M47.83 M77.61 M 77.61 M Cash from financing activities 262.54 M39.26 M6.25 M15.04 M91.54 M11.89 M 11.89 M Free cash flow 16.07 M-23.09 M2.83 M37.55 M55 M7.12 M 7.12 M

Новости

Stifel подтверждает рейтинг акций Glaukos на фоне роста продаж

Stifel reiterates Glaukos stock rating on product momentum

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

Needham повысил целевую цену акций Glaukos на фоне роста iDose и Epioxa

Needham raises Glaukos stock price target on iDose, Epioxa growth

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript

Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say

Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

Glaukos представит отчетность на фоне запуска iDose и Epioxa

Glaukos earnings on deck as iDose, Epioxa launches converge

Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth